Cystic Fibrosis (CF) Diagnostics Market: Global Market Estimation, Dynamics, Regional Share, Trends, Competitor Analysis 2016 to 2021 and Forecast 2022 to 2028

$ PRICE - $ 3,000.00 – $ 8,900.00

Cystic Fibrosis (CF) Diagnostics Market By Test Type (Antenatal testing, Carrier testing, Sweat tests, CFTR-Related Metabolic Syndrome (CRMS), Newborn screening, Prenatal screening), by Product Type (Diagnostic Kits, Reagents, and Others) End User (Hospitals and Diagnostic Centers) and Geography (North America, Latin America, Europe, Middle East and Africa, Asia Pacific)

Request Sample

Request Methodology

Request Sample

$ PRICE - $ 3,000.00 – $ 8,900.00

Clear selection

SKU: N/A Categories: Biotechnology, Healthcare

Description
Table Of Content
Company Profile

Report

Description

Cystic Fibrosis (CF) Diagnostics Market size was valued at USD 7.13 billion in 2021, growing at a CAGR of 18% from 2022-28. Cystic fibrosis (CF) is a chronic, genetic disease that causes persistent lung infections and limits the ability to breathe over time. Several mutations in the gene is responsible for Cystic fibrosis that encodes cystic fibrosis transmembrane conductance regulator (CFTR) protein. Patients with CF have inherited two copies of the defective CF gene one copy from each parent. Both parents must have at least one copy of the defective gene. Currently there are approximately 70,000 people who are suffering from cystic fibrosis worldwide, according to the Cystic Fibrosis Foundation (CFF). Some of the popular methods of diagnosis are antenatal testing, carrier testing, and other tests such as genetic tests and sweat tests According to Cystic Fibrosis Foundation, the incidence of these hereditary disorders is constantly growing. The nonprofit organizations are investing huge amount of funds to find various therapeutics for CF and to support the research & developmental activities. This report studies global Cystic Fibrosis (CF) Diagnostics Market dynamics elaborately to identify the current trends & drivers, future opportunities and possible challenges to the key stakeholders operating in the market. In addition, the market report includes human demographics; regulatory scenario, and competition analysis with vividly illustrated the competition dashboard to assess the market competition. Moreover, PBI analyzed the market to better equip clients with possible investment opportunities across the regions (regional Investment Hot-Spots) and market unmet needs (Product opportunities). Key stakeholders of the report include suppliers, manufacturers, marketers, policymakers, and healthcare service providers engaged.

Key Developments:

In February 2018, Luminex’s xTAG Cystic Fibrosis 71 Kit v2 was approved for sale with LICENSALE.COM in Brazil.

In March 2017, Elucigene Diagnostics announced the official launch of new CF-Italia kit (CF1ITB1).

In April 2017, Elucigene Diagnostics partnered with Southern Cross Diagnostics in order to expand in Australia and New Zealand markets

Cystic Fibrosis (CF) Diagnostics Market

MARKET SUMMARY

18%

Study Period– 2022 – 2028
Base Year– 2021
CAGR– 18%
Largest Market– North America
Fastest Growing Market– Europe

Cystic Fibrosis (CF) Diagnostics Market Analysis

Cystic Fibrosis (CF) Diagnostics Market report gives a comprehensive outlook across the globe with special emphasis on key regions such as North America, Europe, Asia Pacific, Latin America, and Middle East and Africa.
The report on gives historical, current, and future market sizes (US$ Mn) on the basis of product type, test type end-user, and region.

Market Leaders

Elucigene
Asper Biogene
ELITechGroup
Natera, Inc.
Randox Laboratories Ltd.
Luminex Corporation
Appolon Bioteck
Arazy Group
Illumina Inc.

Cystic Fibrosis (CF) Diagnostics Market

Drivers and Restraints

The major driver for the market is improved diagnostic technologies. Increase in investment and awareness about genetic diseases are aiding in development of diagnostic technologies, which will fuel the market growth. The high cost of the drugs and treatment may hamper the growth of the market. The global cystic fibrosis diagnostics market is expected to witness tremendous growth. Novel diagnostic tools for cystic fibrosis are being developed. The scientists at Stanford University, have developed a DNA test for the accurate and comprehensive screening of newborns for cystic fibrosis. By this test the next-generation DNA sequencing can be identified and this test is considered to be less expensive and less time-consuming technology.

Cystic Fibrosis (CF) Diagnostics Market Regional Analysis

North America dominates the market

Geographically, global Cystic Fibrosis (CF) Diagnostics market is segmented into North America, Europe, Asia Pacific, Latin America, and Middle East and Africa. The higher incidence rate of cystic fibrosis is observed in North America. The median age of the person with cystic fibrosis is currently 33.4 years according cystic fibrosis foundation’s national patient registry. Followed by North America is the European region which has more affected population with cystic fibrosis. Out of this affected population, 51.8% were adults and 48.2% were less than 18 years old. Whereas the birth prevalence of CF is higher in United Kingdom, Ireland, Romania, and Bulgaria. When it comes to the Asian region, the prevalence of cystic fibrosis is seen to be very low. The Middle East and Africa holds the lowest share in the market, especially countries in the African region.

Latin-America

North-America

Europe

Asia-Pacific

Middle East

Key

Features of the Report

The report provides granular level information about the market size, regional market share, historic market (2016-2021), and forecast (2022-2028)
The report covers in-detail insights about the competitor’s overview, company share analysis, key market developments, and key strategies
The report outlines drivers, restraints, unmet needs, and trends that are currently affecting the market
The report tracks recent innovations, key developments and startup’s details that are actively working in the market
The report provides plethora of information about market entry strategies, regulatory framework and reimbursement scenario
The report analyses the impact of the socio-political environment through PESTLE Analysis and competition through Porter’s Five Force Analysis in addition to recent technology advancements and innovations in the market

Cystic Fibrosis (CF) Diagnostics Market Segmentation

Test Type

Antenatal Testing
Carrier Testing
Sweat Tests
CFTR-Related Metabolic Syndrome (CRMS)
Newborn Screening
Prenatal Screening

Product Type

Diagnostic Kits
Reagents
Others

End User

Hospital
Diagnostic centers

Geography

North America
Europe
Asia Pacific
Latin America
Middle East and Africa.

Location

GEOGRAPHY

Frequently Asked Questions

2021 is the base year and 2028 is the forecast year.

The report covers the five regions and 15+ countries market data: North America (United States, Canada), Europe (Germany, France, Italy, Spain, and United Kingdom (UK), Asia Pacific (China, India, Japan, Australia & New Zealand), Latin America (Brazil, Mexico, Argentina) and Middle East and Africa (Saudi Arabia, United Arab Emirates, South Africa).

In our report, we provide 12-15 market players’ information into the report. However, based on the client’s request we will provide additional country and regional market players information as well.

Report

Table Of Content

Executive Summary
Global Cystic Fibrosis (CF) Diagnostics Market Introduction
- Global Cystic Fibrosis (CF) Diagnostics Market – Taxonomy
- Global Cystic Fibrosis (CF) Diagnostics Market –Definitions
  - Test Type
  - Product Type
  - End User

Global Cystic Fibrosis (CF) Diagnostics Market Dynamics
- Drivers
- Restraints
- Opportunities/Unmet Needs of the Market
- Trends
- Global Cystic Fibrosis (CF) Diagnostics Market Dynamic Factors – Impact Analysis
- Global Cystic Fibrosis (CF) Diagnostics Market – Competition Landscape
- Epidemiology
Global Cystic Fibrosis (CF) Diagnostics Market Analysis,2015 – 2019 and Forecast, 2020 – 2026
- Market Analysis, 2015 – 2019 and Forecast, 2020 – 2026 (Revenue, USD Mn)
- Year-over-Year (Y-o-Y) Growth Analysis (%)
- Market OpportunityAnalysis
Global Cystic Fibrosis (CF) Diagnostics Market, By Test Type, 2015 – 2019 and Forecast, 2020 – 2026 (Revenue, USD Mn)
- Antenatal Testing
  - Market Analysis, 2015 – 2019 and Forecast, 2020 – 2026 (Revenue, USD Mn)
  - Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
  - Market Opportunity Analysis
- Carrier Testing
  - Market Analysis, 2015 – 2019 and Forecast, 2020 – 2026 (Revenue, USD Mn)
  - Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
  - Market Opportunity Analysis
- Sweat Tests
  - Market Analysis, 2015 – 2019 and Forecast, 2020 – 2026 (Revenue, USD Mn)
  - Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
  - Market Opportunity Analysis
- CFTR-Related Metabolic Syndrome (CRMS)
  - Market Analysis, 2015 – 2019 and Forecast, 2020 – 2026 (Revenue, USD Mn)
  - Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
  - Market Opportunity Analysis
- Newborn Screening
  - Market Analysis, 2015 – 2019 and Forecast, 2020 – 2026 (Revenue, USD Mn)
  - Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
  - Market Opportunity Analysis
- Prenatal Screening
  - Market Analysis, 2015 – 2019 and Forecast, 2020 – 2026 (Revenue, USD Mn)
  - Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
  - Market Opportunity Analysis

Global Cystic Fibrosis (CF) Diagnostics Market Forecast, By Product Type, 2015 – 2019 and Forecast, 2020 – 2026
- Diagnostic Kits
  - Market Analysis, 2015 – 2019 and Forecast, 2020 – 2026 (Revenue, USD Mn)
  - Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
  - Market Opportunity Analysis
- Reagents
  - Market Analysis, 2015 – 2019 and Forecast, 2020 – 2026 (Revenue, USD Mn)
  - Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
  - Market Opportunity Analysis
- Others
  - Market Analysis, 2015 – 2019 and Forecast, 2020 – 2026 (Revenue, USD Mn)
  - Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
  - Market Opportunity Analysis

Global Cystic Fibrosis (CF) Diagnostics Market Forecast, By End User, 2015 – 2019 and Forecast, 2020 – 2026 (Revenue, USD Mn)
- Hospital
  - Market Analysis, 2015 – 2019 and Forecast, 2020 – 2026 (Revenue, USD Mn)
  - Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
  - Market Opportunity Analysis
- Diagnostic centers
  - Market Analysis, 2015 – 2019 and Forecast, 2020 – 2026 (Revenue, USD Mn)
  - Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
  - Market Opportunity Analysis

Global Cystic Fibrosis (CF) Diagnostics Market Forecast, By Region, 2015 – 2019 and Forecast, 2020 – 2026 (Revenue, USD Mn)
- North America
  - Market Analysis, 2015 – 2019 and Forecast, 2020 – 2026 (Revenue, USD Mn)
  - Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
  - Market Opportunity Analysis
- Europe
  - Market Analysis, 2015 – 2019 and Forecast, 2020 – 2026 (Revenue, USD Mn)
  - Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
  - Market Opportunity Analysis
- Asia-Pacific
  - Market Analysis, 2015 – 2019 and Forecast, 2020 – 2026 (Revenue, USD Mn)
  - Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
  - Market Opportunity Analysis
- Latin America
  - Market Analysis, 2015 – 2019 and Forecast, 2020 – 2026 (Revenue, USD Mn)
  - Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
  - Market Opportunity Analysis
- Middle East and Africa
  - Market Analysis, 2015 – 2019 and Forecast, 2020 – 2026 (Revenue, USD Mn)
  - Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
  - Market Opportunity Analysis
- Global Cystic Fibrosis (CF) Diagnostics Market – Opportunity Analysis Index, By Test Type, By Product Type, By End User, and Region, 2020 – 2026
North America Cystic Fibrosis (CF) Diagnostics MarketAnalysis,2015 – 2019 and Forecast, 2020 – 2026 (Revenue, USD Mn)
- Test Type Analysis 2015 – 2019 and Forecast 2020 – 2026 by Revenue (USD Mn),Y-o-Y Growth (%), and Market Share (%)
  - Antenatal Testing
  - Carrier Testing
  - Sweat Tests
  - CFTR-Related Metabolic Syndrome (CRMS)
  - Newborn Screening
  - Prenatal Screening
- Product Type Analysis 2015 – 2019 and Forecast 2020 – 2026 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
  - Diagnostic Kits
  - Reagents
  - Others
- End User Analysis 2015 – 2019 and Forecast 2020 – 2026 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
  - Hospital
  - Diagnostic centers
- Country Analysis 2016 and Forecast 2020 – 2026 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
  - US.
  - Canada
- North America Cystic Fibrosis (CF) Diagnostics Market – Opportunity Analysis Index, By Test Type, By Product Type, By End User, and Country, 2020 – 2026
- North America Cystic Fibrosis (CF) Diagnostics Market Dynamics – Trends
Europe Cystic Fibrosis (CF) Diagnostics Market Analysis, 2015 – 2019 and Forecast, 2020 – 2026 (Revenue, USD Mn)
- Test Type Analysis 2015 – 2019 and Forecast 2020 – 2026 by Revenue (USD Mn),Y-o-Y Growth (%), and Market Share (%)
  - Antenatal Testing
  - Carrier Testing
  - Sweat Tests
  - CFTR-Related Metabolic Syndrome (CRMS)
  - Newborn Screening
  - Prenatal Screening
- Product Type Analysis 2015 – 2019 and Forecast 2020 – 2026 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
  - Diagnostic Kits
  - Reagents
  - Others
- End User Analysis 2015 – 2019 and Forecast 2020 – 2026 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
  - Hospital
  - Diagnostic centers
- Country Analysis 2015 – 2019 and Forecast 2020 – 2026 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
  - Germany
  - UK
  - France
  - Spain
  - Italy
  - Russia
  - Poland
  - Rest of Europe
- Europe Cystic Fibrosis (CF) Diagnostics Market – Opportunity Analysis Index, By Test Type, By Product Type, By End User, and Country, 2020 – 2026
- Europe Cystic Fibrosis (CF) Diagnostics Market Dynamics – Trends
Asia-Pacific Cystic Fibrosis (CF) Diagnostics Market Analysis, 2015 – 2019 and Forecast, 2020 – 2026 (Revenue, USD Mn)
- Test Type Analysis 2015 – 2019 and Forecast 2020 – 2026 by Revenue (USD Mn),Y-o-Y Growth (%), and Market Share (%)
  - Antenatal Testing
  - Carrier Testing
  - Sweat Tests
  - CFTR-Related Metabolic Syndrome (CRMS)
  - Newborn Screening
  - Prenatal Screening
- Product Type Analysis 2015 – 2019 and Forecast 2020 – 2026 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
  - Diagnostic Kits
  - Reagents
  - Others
- End User Analysis 2015 – 2019 and Forecast 2020 – 2026 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
  - Hospital
  - Diagnostic centers
- Country Analysis2015 – 2019 and Forecast 2020 – 2026 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
  - Japan
  - China
  - India
  - ASEAN
  - Australia & New Zealand
  - Rest of Asia-Pacific
- Asia-Pacific Cystic Fibrosis (CF) Diagnostics Market – Opportunity Analysis Index, By Test Type, By Product Type, By End User, and Country, 2020 – 2026
- Asia-Pacific Cystic Fibrosis (CF) Diagnostics Market Dynamics – Trends
Latin America Cystic Fibrosis (CF) Diagnostics Market Analysis, 2015 – 2019 and Forecast, 2020 – 2026 (Revenue, USD Mn)
- Test Type Analysis 2015 – 2019 and Forecast 2020 – 2026 by Revenue (USD Mn),Y-o-Y Growth (%), and Market Share (%)
  - Antenatal Testing
  - Carrier Testing
  - Sweat Tests
  - CFTR-Related Metabolic Syndrome (CRMS)
  - Newborn Screening
  - Prenatal Screening
- Product Type Analysis 2015 – 2019 and Forecast 2020 – 2026 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
  - Diagnostic Kits
  - Reagents
  - Others
- End User Analysis 2015 – 2019 and Forecast 2020 – 2026 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
  - Hospital
  - Diagnostic centers
- Country Analysis 2015 – 2019 and Forecast 2020 – 2026 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
  - Brazil
  - Mexico
  - Argentina
  - Venezuela
  - Rest of Latin America
- Latin America Cystic Fibrosis (CF) Diagnostics Market – Opportunity Analysis Index, By Test Type, By Product Type, By End User, and Country, 2020 – 2026
- Latin America Cystic Fibrosis (CF) Diagnostics Market Dynamics – Trends
Middle East and Africa Cystic Fibrosis (CF) Diagnostics Market Analysis, 2015 – 2019 and Forecast, 2020 – 2026 (Revenue, USD Mn)
- Test Type Analysis 2015 – 2019 and Forecast 2020 – 2026 by Revenue (USD Mn),Y-o-Y Growth (%), and Market Share (%)
  - Antenatal Testing
  - Carrier Testing
  - Sweat Tests
  - CFTR-Related Metabolic Syndrome (CRMS)
  - Newborn Screening
  - Prenatal Screening
- Product Type Analysis 2015 – 2019 and Forecast 2020 – 2026 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
  - Diagnostic Kits
  - Reagents
  - Others
- End User Analysis 2015 – 2019 and Forecast 2020 – 2026 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
  - Hospital
  - Diagnostic centers
- Country Analysis 2015 – 2019 and Forecast 2020 – 2026 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
  - Gulf Cooperation Council (GCC) Countries
  - Israel
  - South Africa
  - Rest of MEA
- MEA Cystic Fibrosis (CF) Diagnostics Market – Opportunity Analysis Index, By Test Type, By Product Type, By End User, and Country, 2020 – 2026
- MEA Cystic Fibrosis (CF) Diagnostics Market Dynamics – Trends
Competition Landscape
- Strategic Dashboard of Top Market Players
- Company Profiles (Introduction, Financial Analysis, Test Type& Service Offerings, Key Developments, Strategies, and SWOT Analysis)
  - Elucigene
  - Asper Biogene
  - ELITechGroup
  - Natera, Inc.
  - Randox Laboratories Ltd.
  - Luminex Corporation
  - Appolon Bioteck
  - Arazy Group
  - Illumina Inc.

Research Methodology
Key Assumptions and Acronyms

Disclaimer

The above mentioned segmentation is tentative; it is changed according to client’s requirement, or research feasibility.

Description

Description

Key Developments:

In February 2018, Luminex’s xTAG Cystic Fibrosis 71 Kit v2 was approved for sale with LICENSALE.COM in Brazil.

In March 2017, Elucigene Diagnostics announced the official launch of new CF-Italia kit (CF1ITB1).

In April 2017, Elucigene Diagnostics partnered with Southern Cross Diagnostics in order to expand in Australia and New Zealand markets

search

Cystic Fibrosis (CF) Diagnostics Market: Global Market Estimation, Dynamics, Regional Share, Trends, Competitor Analysis 2016 to 2021 and Forecast 2022 to 2028

Description

Cystic Fibrosis (CF) Diagnostics Market Analysis

Drivers and Restraints

North America dominates the market

Features of the Report

Test Type

Product Type

End User

Geography

GEOGRAPHY

Frequently Asked Questions

Table Of Content

Company Profile

Description

Product categories

Our Clients

ASIA PACIFIC OFFICE

EUROPE OFFICE